PFKFB3 and non-small cell lung carcinoma: Meanwhile, clear evidence shows that PFKFB3, when used as a key enzyme of glycolysis, is also notably elevated in liver cancer [32], osteoma [33], breast cancer [34] and NSCLC [35], indicating the tight association of PFKFB3 with the prognosis of tumors.